Studies have shown that the activity of the ERCC1‐XPF complex can reflect the efficiency of NER, and the ERCC1‐XPF complex repairs DNA DSBs via HR, thus, causing cisplatin resistance in lung cancer.146, 147. This evidence concerns the gene ERCC4 and lung carcinoma.